Venus Remedies completes phase IV of Baddi Project
Pharmaceutical company Venus Remedies said it has completed and put on trials the last stage of phase IV of the multi-crore Baddi Project, which started in April 2005.
By PTI |
MUMBAI: Pharmaceutical company Venus Remedies on Tuesday said it has completed and put on trials the last stage of phase IV of the multi-crore Baddi Project, which started in April 2005.
"The phase IV of the Baddi Project, which consists of two plants for speciality formulations one for pre-filled injectable filling in glass syringes and a plant for hormones in injections, have been completed in all respects," the Chandigarh-based firm informed the Bombay Stock Exchange.
The plants have now been put under validation runs and trial production, it added.
Venus Remedies said the pre-filled syringe (PFS) facility has a production capacity of 10,000 pieces per day in a single shift while the hormones plant has the capacity of making 25,000 pieces a day.
With the completion of these two plants, all the eight units have been set up ahead of the scheduled December deadline, the company claimed.
"The phase IV of the Baddi Project, which consists of two plants for speciality formulations one for pre-filled injectable filling in glass syringes and a plant for hormones in injections, have been completed in all respects," the Chandigarh-based firm informed the Bombay Stock Exchange.
The plants have now been put under validation runs and trial production, it added.
Venus Remedies said the pre-filled syringe (PFS) facility has a production capacity of 10,000 pieces per day in a single shift while the hormones plant has the capacity of making 25,000 pieces a day.
With the completion of these two plants, all the eight units have been set up ahead of the scheduled December deadline, the company claimed.
Start a SIP with as low as ₹500 with ET Money App!
Download
The Economic Times News App for Quarterly Results, Latest News in ITR, Business, Share Market, Live Sensex News & More.
The Economic Times News App for Quarterly Results, Latest News in ITR, Business, Share Market, Live Sensex News & More.
ADVERTISEMENT
